TW201334824A - Production method for pre-filled syringe outer tube and production method for injection molding mold - Google Patents
Production method for pre-filled syringe outer tube and production method for injection molding mold Download PDFInfo
- Publication number
- TW201334824A TW201334824A TW101144107A TW101144107A TW201334824A TW 201334824 A TW201334824 A TW 201334824A TW 101144107 A TW101144107 A TW 101144107A TW 101144107 A TW101144107 A TW 101144107A TW 201334824 A TW201334824 A TW 201334824A
- Authority
- TW
- Taiwan
- Prior art keywords
- outer cylinder
- injection molding
- hard film
- syringe
- group
- Prior art date
Links
- 229940071643 prefilled syringe Drugs 0.000 title claims abstract description 78
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 43
- 238000001746 injection moulding Methods 0.000 title claims abstract description 39
- 125000004122 cyclic group Chemical group 0.000 claims abstract description 36
- 229920005672 polyolefin resin Polymers 0.000 claims abstract description 36
- 230000003746 surface roughness Effects 0.000 claims abstract description 27
- 239000011342 resin composition Substances 0.000 claims abstract description 16
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 15
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 10
- 229910052804 chromium Inorganic materials 0.000 claims abstract description 10
- 229910052719 titanium Inorganic materials 0.000 claims abstract description 10
- 229910052726 zirconium Inorganic materials 0.000 claims abstract description 10
- 229910052759 nickel Inorganic materials 0.000 claims abstract description 9
- 238000000034 method Methods 0.000 claims description 48
- 238000000227 grinding Methods 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 5
- 238000002834 transmittance Methods 0.000 claims description 5
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 4
- 229910010037 TiAlN Inorganic materials 0.000 claims description 3
- 239000002994 raw material Substances 0.000 abstract description 8
- 230000001050 lubricating effect Effects 0.000 abstract description 3
- 238000005516 engineering process Methods 0.000 abstract 1
- -1 polypropylene Polymers 0.000 description 24
- 239000003814 drug Substances 0.000 description 20
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 15
- 238000005498 polishing Methods 0.000 description 15
- 229920005989 resin Polymers 0.000 description 13
- 239000011347 resin Substances 0.000 description 13
- 229940079593 drug Drugs 0.000 description 12
- 239000010432 diamond Substances 0.000 description 9
- 229910003460 diamond Inorganic materials 0.000 description 9
- 239000004711 α-olefin Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 229920001577 copolymer Polymers 0.000 description 6
- 150000002430 hydrocarbons Chemical group 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- WKBPZYKAUNRMKP-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)pentyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(CCC)CN1C=NC=N1 WKBPZYKAUNRMKP-UHFFFAOYSA-N 0.000 description 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 238000007334 copolymerization reaction Methods 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 239000001257 hydrogen Substances 0.000 description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 238000005240 physical vapour deposition Methods 0.000 description 4
- 231100000241 scar Toxicity 0.000 description 4
- 239000003082 abrasive agent Substances 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000996 additive effect Effects 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 2
- 239000005977 Ethylene Substances 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- 239000004743 Polypropylene Substances 0.000 description 2
- 125000004018 acid anhydride group Chemical group 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-N alpha-methacrylic acid Natural products CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 2
- 125000003277 amino group Chemical group 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 238000005229 chemical vapour deposition Methods 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000007772 electroless plating Methods 0.000 description 2
- 125000003700 epoxy group Chemical group 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 125000002743 phosphorus functional group Chemical group 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 2
- 238000002627 tracheal intubation Methods 0.000 description 2
- 238000007740 vapor deposition Methods 0.000 description 2
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- OFNISBHGPNMTMS-UHFFFAOYSA-N 3-methylideneoxolane-2,5-dione Chemical compound C=C1CC(=O)OC1=O OFNISBHGPNMTMS-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 102000005591 NIMA-Interacting Peptidylprolyl Isomerase Human genes 0.000 description 1
- 108010059419 NIMA-Interacting Peptidylprolyl Isomerase Proteins 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 239000006061 abrasive grain Substances 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 125000001118 alkylidene group Chemical group 0.000 description 1
- 101150059062 apln gene Proteins 0.000 description 1
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000012661 block copolymerization Methods 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009713 electroplating Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 125000000219 ethylidene group Chemical group [H]C(=[*])C([H])([H])[H] 0.000 description 1
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000009477 glass transition Effects 0.000 description 1
- 125000003055 glycidyl group Chemical group C(C1CO1)* 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007733 ion plating Methods 0.000 description 1
- 238000001659 ion-beam spectroscopy Methods 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 238000001755 magnetron sputter deposition Methods 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000005649 metathesis reaction Methods 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000002667 nucleating agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000005268 plasma chemical vapour deposition Methods 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 239000002685 polymerization catalyst Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 239000012748 slip agent Substances 0.000 description 1
- 239000011029 spinel Substances 0.000 description 1
- 229910052596 spinel Inorganic materials 0.000 description 1
- 238000004544 sputter deposition Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000000870 ultraviolet spectroscopy Methods 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C45/00—Injection moulding, i.e. forcing the required volume of moulding material through a nozzle into a closed mould; Apparatus therefor
- B29C45/17—Component parts, details or accessories; Auxiliary operations
- B29C45/26—Moulds
- B29C45/27—Sprue channels ; Runner channels or runner nozzles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/3129—Syringe barrels
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C45/00—Injection moulding, i.e. forcing the required volume of moulding material through a nozzle into a closed mould; Apparatus therefor
- B29C45/0025—Preventing defects on the moulded article, e.g. weld lines, shrinkage marks
- B29C2045/0027—Gate or gate mark locations
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
- B29L2031/00—Other particular articles
- B29L2031/753—Medical equipment; Accessories therefor
- B29L2031/7544—Injection needles, syringes
Abstract
Description
本發明係關於一種預填注射器用外筒的製造方法、以及可以使用在該製造方法之射出成形用模具的製造方法。 The present invention relates to a method for producing an outer cylinder for a prefilled syringe, and a method for producing an injection molding mold which can be used in the production method.
向來一般之注射器係在使用時,藉由上吸藥劑之方法而進行使用。但是,該使用方法係容易發生操作之效率變差或者是藥劑之填充失誤等之人類錯誤。於是,在最近,最好是使用預先填充規定量之規定藥劑之預填注射器。 A conventional syringe has been used by a method of sucking up a drug at the time of use. However, this method of use is prone to human error in the efficiency of the operation or the filling failure of the drug. Thus, recently, it has been preferred to use a prefilled syringe that is prefilled with a prescribed amount of prescribed medicament.
構成預填注射器之材料係由輕量、不容易破裂等之處理容易性等之觀點來看的話,則最好是樹脂。但是,將使用在一般之注射器製造之聚丙烯予以使用而製造之預填注射器係聚丙烯之耐熱性變低,因此,由於填充藥劑之前之水蒸氣殺菌而產生變形之問題。 The material constituting the prefilled syringe is preferably a resin from the viewpoints of ease of handling such as being lightweight, not easily broken, and the like. However, the heat resistance of the prefilled syringe-based polypropylene which is produced by using polypropylene which is produced by a general syringe is low, and therefore, there is a problem that deformation occurs due to sterilization of water vapor before filling the chemical.
此外,由於使用之樹脂種類而使得樹脂之耐藥品性呈不充分,結果,在預填注射器之保管中,發生包含於樹脂之成分來溶出於藥劑中等之問題。此外,在預填注射器之水蒸氣障蔽性變低之時,包含於藥劑之水分係在保管時,發生揮發之問題。 Further, the chemical resistance of the resin is insufficient due to the type of the resin to be used. As a result, in the storage of the prefilled syringe, the component contained in the resin is dissolved in the drug. Further, when the water vapor barrier property of the prefilled syringe is lowered, the moisture contained in the drug is volatilized during storage.
因此,限定在可以使用作為預填注射器原料之樹脂,作為可以使用之樹脂係列舉例如記載於專利文獻1之芳香族乙烯系聚合物。 For this reason, it is limited to the resin which can be used as a raw material of a prefilled syringe, and the series of the resin which can be used, for example, the aromatic vinyl type polymer of the patent document 1 is mentioned.
【專利文獻1】日本特開平11-164887號公報 [Patent Document 1] Japanese Patent Laid-Open No. Hei 11-164887
但是,環狀烯烴樹脂係知道成為耐熱性、耐藥品性、水蒸氣障蔽性等呈良好之樹脂。此外,環狀烯烴樹脂係也具有良好之透明性,因此,在使用環狀烯烴樹脂而製造預填注射器之時,也得到所謂容易辨識藥劑之效果。 However, the cyclic olefin resin is known to be a resin which is excellent in heat resistance, chemical resistance, and water vapor barrier properties. Further, since the cyclic olefin resin also has good transparency, when a prefilled syringe is produced by using a cyclic olefin resin, the effect of easily identifying the drug is also obtained.
本發明人們係由於改善樹脂製之預填注射器之性能之目的而在嘗試製造以環狀烯烴樹脂來作為原料之預填注射器用外筒之時,製造之預填注射器用外筒之透明性變得不良好,並且,在成形性,存在有問題。 The inventors of the present invention have attempted to manufacture an outer cylinder for a prefilled syringe using a cyclic olefin resin as a raw material for the purpose of improving the performance of a prefilled syringe made of a resin, and the transparency of the outer cylinder for prefilled syringe manufactured is changed. It is not good, and there is a problem in formability.
本發明係為了解決前述之課題而完成的,其目的係提供一種以環狀烯烴樹脂作為原料而進行製造且呈效率良好地製造具有高度透明性之預填注射器用外筒的技術。 The present invention has been made to solve the above problems, and an object of the invention is to provide a technique for producing an outer cylinder for a prefilled syringe having high transparency by efficiently producing a cyclic olefin resin as a raw material.
本發明人們係為了解決前述之課題,因此,為了以環狀烯烴樹脂作為原料而進行製造且製造具有高度透明性之預填注射器用外筒,所以,全心重複地進行研究。結果發現: 如果是用以成形預填注射器用外筒而構成射出成形用模具之芯部(可動側)之表面粗糙度位處於特定之範圍且在芯部之表面上形成特定之潤滑性硬質皮膜且研磨其潤滑性硬質皮膜之表面的話,則得到非常高之透明性之預填注射器用外筒,以致於完成本發明。更加具體地說,本發明係提供以下者。 In order to solve the above-mentioned problems, the inventors of the present invention have studied the use of a cyclic olefin resin as a raw material and manufactured an outer cylinder for a prefilled syringe having high transparency. turn out: The surface roughness of the core portion (movable side) constituting the injection molding die for forming the outer cylinder for pre-filling the syringe is within a specific range and a specific lubricious hard film is formed on the surface of the core portion and ground. In the case of the surface of the lubricious hard film, an outer cylinder for prefilled syringes having a very high transparency is obtained, so that the present invention has been completed. More specifically, the present invention provides the following.
(1):一種預填注射器用外筒的製造方法,係製造對於環狀烯烴樹脂組成物來進行射出成形而組成之預填注射器用外筒的方法,將構成射出成形用模具之芯部之表面粗糙度Rz(十點平均粗糙度)為50μm以下且形成包含由Ti、Cr、Zr、C、Al和Ni而選出之至少一種元素之潤滑性硬質皮膜且研磨前述潤滑性硬質皮膜之表面的射出成形用模具予以使用,對於預填注射器用外筒之側壁呈垂直地射入之波長450nm之光來透過前述側壁時之光線透過率為70%以上。 (1) A method for producing a pre-filled syringe outer cylinder, which is a method for producing an outer cylinder for pre-filling a syringe which is formed by injection molding a cyclic olefin resin composition, and which constitutes a core portion of an injection molding die The surface roughness Rz (ten-point average roughness) is 50 μm or less, and a lubricative hard film containing at least one element selected from the group consisting of Ti, Cr, Zr, C, Al, and Ni is formed and the surface of the lubricious hard film is polished. The injection molding die is used, and the light transmittance of the light beam having a wavelength of 450 nm which is vertically incident on the side wall of the outer cylinder for prefilling the syringe passes through the side wall is 70% or more.
(2):如申請專利範圍第1項所記載之預填注射器用外筒的製造方法,前述之潤滑性硬質皮膜係由擬鑽石碳(DLC)、CrN、TiN、TiC、TiCN、TiAlN、TiCrN、AlCrN、ZrN或Ni而構成。 (2) The method for producing a pre-filled syringe outer cylinder according to the first aspect of the invention, wherein the lubricative hard film is made of diamond-like carbon (DLC), CrN, TiN, TiC, TiCN, TiAlN, TiCrN It is composed of AlCrN, ZrN or Ni.
(3):如申請專利範圍第1或2項所記載之預填注射器用外筒的製造方法,構成射出成形用模具之芯部之離模斜率係實質為0度。 (3) The method for producing a pre-filled syringe outer cylinder according to the first or second aspect of the invention, wherein the core of the injection molding die has a mold release slope of substantially 0 degrees.
(4):一種射出成形用模具的製造方法,係製造用以製造預填注射器用外筒之射出成形用模具之射出成形用模具製造方法,包括:使得構成射出成形用模具之芯部之表面粗糙度Rz成為 50μm以下之芯部表面粗糙度調整製程;對於前述調整製程後之芯部,形成包含由Ti、Cr、Zr、C、Al和Ni而選出之至少一種元素之潤滑性硬質皮膜之潤滑性硬質皮膜形成製程;以及研磨前述潤滑性硬質皮膜之表面之研磨製程。 (4) A method for producing an injection molding die for producing an injection molding die for producing an injection molding die for prefilling a syringe, comprising: forming a surface of a core portion of the injection molding die Roughness Rz becomes a core surface roughness adjustment process of 50 μm or less; for the core portion after the adjustment process, a lubricative hard film containing a lubricative hard film of at least one element selected from Ti, Cr, Zr, C, Al, and Ni is formed Forming a process; and grinding a surface of the surface of the aforementioned lubricious hard film.
如果藉由本發明的話,則可以使用環狀烯烴樹脂,來作為原料,呈效率良好地製造具有高度透明性之預填注射器用外筒。 According to the present invention, a cyclic olefin resin can be used as a raw material, and an outer cylinder for a prefilled syringe having high transparency can be efficiently produced.
1‧‧‧預填注射器 1‧‧‧Prefilled syringe
10‧‧‧預填注射器用外筒 10‧‧‧Prefilled syringe outer cylinder
20‧‧‧插管 20‧‧‧Intubation
30‧‧‧柱塞 30‧‧‧Plunger
101‧‧‧吸引部 101‧‧‧Attraction
102‧‧‧凸緣 102‧‧‧Flange
201‧‧‧擋塊 201‧‧ ‧block
圖1係呈示意地顯示預填注射器之圖,圖1(a)係立體圖,圖1(b)係圖1(a)之MM剖面圖。 Fig. 1 is a view schematically showing a prefilled syringe, Fig. 1(a) is a perspective view, and Fig. 1(b) is a MM sectional view of Fig. 1(a).
圖2(a)係顯示在實施例來製造之預填注射器用外筒之尺寸之圖,圖2(b)係顯示模具內之澆口、澆道、閘門之位置之圖。 Fig. 2(a) is a view showing the dimensions of the outer cylinder for the prefilled syringe manufactured in the embodiment, and Fig. 2(b) is a view showing the positions of the gate, the runner, and the gate in the mold.
圖3係用以說明光線透過率之測定方法之示意圖。 Fig. 3 is a schematic view for explaining a method of measuring light transmittance.
在以下,就本發明之實施形態而進行說明。此外,本發明係並非限定於以下之實施形態。 Hereinafter, embodiments of the present invention will be described. Further, the present invention is not limited to the following embodiments.
本發明係製造預填注射器用外筒之方法。在本發明來製造之預填注射器用外筒之形狀係並無特別限定。首先,就使用本發明之預填注射器用外筒之一般之預填注射器而言,使用圖式而簡單地進行說明。 The present invention is a method of manufacturing an outer cylinder for prefilling a syringe. The shape of the outer cylinder for the prefilled syringe manufactured by the present invention is not particularly limited. First, a general prefilled syringe using the outer cylinder for prefilled syringe of the present invention will be briefly described using the drawings.
圖1係呈示意地顯示預填注射器之圖。預填注射器1係包括:預填注射器用外筒10、連結於預填注射器用外筒10之某一端之插管20、由預填注射器用外筒10之其他端開始呈可自由進退地插通於預填注射器用外筒10之內部之柱塞30。 Figure 1 is a diagram schematically showing a prefilled syringe. The prefilled syringe 1 includes an outer cylinder 10 for prefilling the syringe, a cannula 20 coupled to one end of the outer cylinder 10 for prefilling the syringe, and a freely retractable insertion from the other end of the outer cylinder 10 for prefilling the syringe. The plunger 30 inside the outer cylinder 10 for pre-filling the syringe is pre-filled.
在預填注射器用外筒10之某一端,形成用以連結於插管20之吸引部101,在其他端,形成凸緣102。此外,預填注射器用外筒10之內部空間係收納藥劑之藥劑收納用空間。由凸緣102側之預填注射器用外筒10之開口開始,插通柱塞30。此外,正如圖1(b)所示,使得預填注射器用外筒10之內壁面之離模斜率成為θ。 At one end of the prefilled syringe outer cylinder 10, a suction portion 101 for connecting to the cannula 20 is formed, and at the other end, a flange 102 is formed. Further, the internal space of the outer cylinder 10 for prefilling the syringe is a space for storing the medicine for the medicine. Starting from the opening of the outer cylinder 10 for the prefilled syringe on the side of the flange 102, the plunger 30 is inserted. Further, as shown in Fig. 1(b), the mold release slope of the inner wall surface of the prefilled syringe outer cylinder 10 is made θ.
插管20係存在端部之擋塊201,該擋塊201係藉由嵌合於前述之吸引部101而連結插管20和預填注射器用外筒10。 The cannula 20 is a stopper 201 having an end portion, and the stopper 201 is coupled to the cannula portion 20 and the prefilled syringe outer cylinder 10 by being fitted to the suction portion 101 described above.
柱塞30係正如前面之敘述,由預填注射器用外筒10之端部開始,呈可自由進退地插通於藥劑收納用空間。在預填注射器之保管時,柱塞30之端部係位處在接觸到藥劑收納用空間內之藥劑之狀態。 The plunger 30 is inserted into the drug storage space so as to be freely retractable from the end of the outer cylinder 10 for prefilling the syringe, as described above. At the time of storage of the prefilled syringe, the end portion of the plunger 30 is in a state of being in contact with the medicine in the drug storage space.
接著,就預填注射器用外筒之製造方法而簡單地進行說明。在以藥劑填充於前述預填注射器1內之狀態來保管一定期間之後,藉由在使用時,還將柱塞30擠入至預填注射器用外筒10之內部而縮小藥劑收納用空間之容積,同時,由吸引部101開始擠壓出藥劑,擠壓出之藥劑係通過插管20之 內而離開至預填注射器之外部。 Next, the method of manufacturing the outer cylinder for prefilling the syringe will be briefly described. After being stored in the prefilled syringe 1 for a predetermined period of time, the plunger 30 is pushed into the outer cylinder 10 for pre-filling the syringe to reduce the volume of the drug storage space. At the same time, the medicament is squeezed out by the suction portion 101, and the extruded medicine is passed through the cannula 20. Leave inside to the outside of the prefilled syringe.
正如前面之敘述,預填注射器1係以藥劑收納於內部之狀態,來保管一定期間。因此,在預填注射器用外筒10由水蒸氣透過性變低之材料來構成之狀態下,發生包含於藥劑之水分來離開至外部之問題。 As described above, the prefilled syringe 1 is stored in a state in which the drug is stored inside for a predetermined period of time. Therefore, in the state in which the outer cylinder 10 for pre-filling the syringe is made of a material having a low water vapor permeability, the problem of moisture contained in the medicine and leaving to the outside occurs.
此外,在以藥劑收納於預填注射器1之內部之狀態來保管長期間之時,長期間地持續藥劑和預填注射器用外筒10之內壁面呈接觸之狀態。因此,在構成預填注射器用外筒10之材料之耐藥品性變低之狀態下,發生其材料之分解物等來溶出於藥劑中之問題。 In addition, when the drug is stored in the inside of the prefilled syringe 1 for a long period of time, the drug continues to be in contact with the inner wall surface of the prefilled syringe outer tube 10 for a long period of time. Therefore, in a state in which the chemical resistance of the material constituting the outer cylinder 10 for prefilling the syringe is lowered, a problem that the decomposition product of the material or the like is dissolved in the medicine occurs.
藉由本發明之製造方法而得到之預填注射器用外筒10係由後面敘述之環狀烯烴樹脂組成物而構成。在環狀烯烴樹脂組成物,出現環狀烯烴樹脂之良好之耐藥品性、水蒸氣障蔽性,因此,在使用環狀烯烴樹脂組成物而製造預填注射器用外筒之狀態下,並無發生前述之問題。 The pre-filled syringe outer cylinder 10 obtained by the production method of the present invention is composed of a cyclic olefin resin composition described later. In the cyclic olefin resin composition, the chemical resistance of the cyclic olefin resin and the water vapor barrier property are exhibited. Therefore, in the state in which the outer cylinder for the prefilled syringe is produced by using the cyclic olefin resin composition, it does not occur. The aforementioned problem.
但是,在企圖使用環狀烯烴樹脂組成物而製造預填注射器用外筒之狀態下,發生所謂預填注射器用外筒不具有充分之透明性之問題。 However, in an attempt to manufacture a pre-filled outer cylinder for a syringe by using a cyclic olefin resin composition, there is a problem that the outer cylinder for the prefilled syringe does not have sufficient transparency.
此外,在以環狀烯烴樹脂組成物來作為原料而製造預填注射器用外筒之時,因為環狀烯烴樹脂之固有之硬度,所以,在製造時,不容易由模具,來取出預填注射器用外筒。在製造時,不容易由模具來取出預填注射器用外筒之問題係在外筒之內面,發生傷痕,也關係到透明性之降低以及生產性之降低。 In addition, when the outer cylinder for prefilled syringe is manufactured using the cyclic olefin resin composition as a raw material, since the hardness of the cyclic olefin resin is inherent, it is not easy to take out the prefilled syringe by the mold at the time of manufacture. Use the outer tube. At the time of manufacture, the problem that the outer cylinder for prefilling the syringe is not easily taken out by the mold is attached to the inner surface of the outer cylinder, and scratches occur, which is also related to a decrease in transparency and a decrease in productivity.
在本發明,藉由以下之方法而製造預填注射器用外筒,因此,可以提高使用環狀烯烴樹脂而製造來組成之預填注射器用外筒之透明性。 According to the present invention, since the outer cylinder for prefilling the syringe is manufactured by the following method, the transparency of the outer cylinder for the prefilled syringe which is produced by using the cyclic olefin resin can be improved.
特別是如果藉由本發明之理想條件而進行製造的話,則可以在製造時,由模具而容易地取出預填注射器用外筒,可以提升高品質之預填注射器用外筒之生產性。 In particular, if the production is carried out under the ideal conditions of the present invention, the outer cylinder for prefilling the syringe can be easily taken out by the mold at the time of manufacture, and the productivity of the outer cylinder for the high-quality prefilled syringe can be improved.
本發明之預填注射器用外筒之製造方法係對於環狀烯烴樹脂組成物來進行射出成形而組成之預填注射器用外筒的製造方法。 The method for producing an outer cylinder for a prefilled syringe according to the present invention is a method for producing an outer cylinder for a prefilled syringe which is formed by injection molding a cyclic olefin resin composition.
在本發明之製造方法,使用將構成射出成形用模具之芯部之表面粗糙度Rz為50μm以下且形成包含由Ti、Cr、Zr、C、Al和Ni而選出之至少一種元素之潤滑性硬質皮膜且研磨潤滑性硬質皮膜之表面之射出成形用模具予以構成之芯部。構成前述射出成形用模具之芯部係可以任何地進行製造,但是,可以使用例如構成藉由以下之方法而製造之射出成形用模具之芯部。 In the production method of the present invention, the surface roughness Rz of the core portion constituting the injection molding die is 50 μm or less, and a lubricative hard material containing at least one element selected from Ti, Cr, Zr, C, Al, and Ni is formed. A core portion formed by a film for injection molding on the surface of a film and a lubricated hard film. The core portion constituting the injection molding die can be produced in any manner. For example, a core portion of the injection molding die manufactured by the following method can be used.
作為構成射出成形用模具之芯部之製造方法之一例係列舉具有以下之(i)~(iii)之製程之製造方法。 An example of a method for producing a core portion of a mold for injection molding is a series of manufacturing methods having the following processes (i) to (iii).
(i)使得構成射出成形用模具之芯部之表面粗糙度Rz成為50μm以下之芯部表面粗糙度調整製程。 (i) A core surface roughness adjustment process in which the surface roughness Rz of the core portion constituting the injection molding die is 50 μm or less.
(ii)對於前述調整製程後之芯部表面,形成包含由Ti、Cr、Zr、C、Al和Ni而選出之至少一種元素之潤 滑性硬質皮膜之潤滑性硬質皮膜形成製程。 (ii) forming, for the surface of the core after the adjustment process, at least one element selected from the group consisting of Ti, Cr, Zr, C, Al, and Ni A lubricious hard film forming process for a slippery hard film.
(iii)研磨前述潤滑性硬質皮膜之表面之研磨製程。 (iii) a grinding process for grinding the surface of the aforementioned lubricious hard film.
(i)之芯部表面粗糙度調整製程係例如在粒度支數之JISR6010,使用2000號以上之研磨材料而研磨芯部表面之製程。在此,研磨材料之粒度支數越大而表面粗糙度Rz越小,粒度支數越小而表面粗糙度Rz越大。因此,可以藉由適度地調整研磨材料之粒度支數而調整表面粗糙度Rz。此外,在研磨時之具體方法係並無特別限定,列舉例如使用鑽石紙等之研磨體之方法、或者是使用液體狀之研磨材料(混合物)和布或海綿製之稱為拋光輪之研磨體之方法、空氣研磨、車床、或者是組合這些方法之方法等。 The core surface roughness adjustment process of (i) is, for example, a process of grinding a core surface using an abrasive material of 2000 or more in JISR6010 of a particle size count. Here, the larger the particle size count of the abrasive material and the smaller the surface roughness Rz, the smaller the particle size count and the larger the surface roughness Rz. Therefore, the surface roughness Rz can be adjusted by appropriately adjusting the particle size count of the abrasive. Further, the specific method at the time of polishing is not particularly limited, and examples thereof include a method of using a polishing body such as diamond paper, or a polishing material (mixture) using a liquid material and a polishing body called a polishing wheel made of a cloth or sponge. Method, air grinding, lathe, or a method of combining these methods, and the like.
在(ii)之潤滑性硬質皮膜形成製程,在(i)之製程後之表面,形成包含由Ti、Cr、Zr、C、Al和Ni而選出之至少一種元素之潤滑性硬質皮膜。在本發明,最好是由擬鑽石碳(DLC)、CrN、TiN、TiC、TiCN、TiAlN、TiCrN、AlCrN、ZrN或Ni而構成之潤滑性硬質皮膜。 In the lubricative hard film forming process of (ii), a lubricative hard film containing at least one element selected from the group consisting of Ti, Cr, Zr, C, Al, and Ni is formed on the surface after the process of (i). In the present invention, a lubricative hard film composed of pseudo diamond carbon (DLC), CrN, TiN, TiC, TiCN, TiAlN, TiCrN, AlCrN, ZrN or Ni is preferred.
作為在芯部之表面來形成潤滑性硬質皮膜之方法係列舉例如堆積法。作為堆積法係適合為氣相法,列舉例如以直流電源、交流電源或高周波電源等來作為電源之電漿CVD(Chemical Vapor Deposition:化學氣相沉積)法等之CVD法、AIP(Arc Ion Plating:電弧離子植入)法等之PVD(Physical Vapor Deposition:物理氣相沉積)法、磁控管濺鍍法、離子束濺鍍法等之濺鍍法、以及離子化蒸鍍法等。此外,在Ni等 之狀態下,列舉電解電鍍、無電解電鍍等之濕式法。這些潤滑性硬質皮膜係可以是單層,也可以是多層。 As a series of methods for forming a lubricative hard film on the surface of the core, for example, a deposition method is used. The gas phase method is preferably a CVD method such as a plasma CVD (Chemical Vapor Deposition) method using a DC power source, an AC power source, or a high-frequency power source as a power source, and AIP (Arc Ion Plating). : PVD (Physical Vapor Deposition) method such as PVD method, sputtering method such as magnetron sputtering method, ion beam sputtering method, and ionization vapor deposition method. In addition, in Ni, etc. In the state, a wet method such as electrolytic plating or electroless plating is listed. These lubricious hard film systems may be a single layer or a plurality of layers.
在(iii)之皮膜表面粗糙度調整製程,成為研磨潤滑性硬質皮膜表面之製程。接著,在研磨後之潤滑性硬質皮膜表面之表面粗糙度Rz係最好是40μm以下。研磨方法係並無特別限定,可以將使用鑽石紙等之研磨體之方法、或者是使用液體狀之研磨材料(混合物)和布或海綿製之稱為拋光輪之研磨體之方法、空氣研磨、車床、或者是組合這些方法之方法等予以採用。此外,為了在研磨時,不剝離潤滑性硬質皮膜,因此,最好是採用鑽石紙。 The film surface roughness adjustment process in (iii) is a process for polishing the surface of the lubricious hard film. Next, the surface roughness Rz of the surface of the lubricative hard film after polishing is preferably 40 μm or less. The polishing method is not particularly limited, and a method of using a polishing body such as diamond paper or a method of using a liquid-like abrasive (mixture) and a cloth or sponge called a polishing body for a polishing wheel, air grinding, or a lathe can be used. Or a method of combining these methods or the like. Further, in order to prevent the lubricating hard film from being peeled off during polishing, it is preferable to use diamond paper.
正如前面之敘述,在本發明,在表面粗糙度Rz為50μm以下之表面,形成包含由Ti、Cr、Zr、C、Al和Ni而選出之至少一種元素之潤滑性硬質皮膜,研磨該潤滑性硬質皮膜之表面。 As described above, in the present invention, a lubricative hard film containing at least one element selected from the group consisting of Ti, Cr, Zr, C, Al, and Ni is formed on the surface having a surface roughness Rz of 50 μm or less, and the lubricity is polished. The surface of the hard film.
為了成為透明性變高且在製造之即刻後而容易由模具來取出之預填注射器用外筒,因此,由於所謂縮小外筒內面之表面粗糙度之理由,所以,必須在表面粗糙度Rz為50μm以下之表面,形成潤滑性硬質皮膜。 In order to obtain a pre-filled syringe outer cylinder which has high transparency and is easily taken out by a mold immediately after the production, the reason for reducing the surface roughness of the inner surface of the outer cylinder is that the surface roughness Rz must be A surface of 50 μm or less forms a lubricious hard film.
此外,潤滑性硬質皮膜係皮膜表面之摩擦係數小於芯部之表面,因此,藉由潤滑性硬質皮膜,形成在芯部之表面,而容易由製造即刻後之模具,來取出預填注射器用外筒。但是,如果無研磨潤滑性硬質皮膜之表面的話,則在形成潤滑性硬質皮膜之際而產生之表面之微細突起係在由模具來取出 預填注射器用外筒之際,有傷害預填注射器用外筒之內壁之狀態發生。因此,為了製造透明性非常高之預填注射器用外筒,所以,即使是在潤滑性硬質皮膜之表面粗糙度Rz變小之狀態下,也必須研磨潤滑性硬質皮膜之表面。 Further, since the friction coefficient of the surface of the lubricative hard coating film is smaller than the surface of the core portion, the lubricative hard film is formed on the surface of the core portion, and it is easy to take out the prefilled syringe by the mold immediately after the manufacture. cylinder. However, if the surface of the hard lubricious hard film is not provided, the fine protrusions on the surface which is formed when the lubricative hard film is formed are taken out by the mold. When the outer cylinder for the syringe is prefilled, there is a state in which the inner wall of the outer cylinder for the prefilled syringe is damaged. Therefore, in order to produce an outer cylinder for a prefilled syringe having a very high transparency, it is necessary to polish the surface of the lubricious hard film even in a state where the surface roughness Rz of the lubricative hard film is small.
但是,在研磨後之潤滑性硬質皮膜之表面粗糙度Rz呈過度大之時,有降低預填注射器用外筒之透明性之狀態發生。因此,研磨後之潤滑性硬質皮膜之表面粗糙度係最好是40μm以下。 However, when the surface roughness Rz of the lubricative hard film after polishing is excessively large, the transparency of the outer cylinder for the prefilled syringe is lowered. Therefore, the surface roughness of the lubricious hard film after polishing is preferably 40 μm or less.
就成為預填注射器用外筒原料之環狀烯烴樹脂組成物而進行說明。在環狀烯烴樹脂組成物,包含環狀烯烴樹脂。 This will be described as a cyclic olefin resin composition for pre-filling the outer tube raw material for a syringe. The cyclic olefin resin composition contains a cyclic olefin resin.
環狀烯烴樹脂係包含環狀烯烴成分,來作為共聚合成分,如果是在主鏈來包含環狀烯烴成分之聚烯烴樹脂的話,則並無特別限定。可以列舉例如環狀烯烴之加成聚合物或其氫添加物、環狀烯烴和α-烯烴之加成共聚物或其氫添加物等。 The cyclic olefin resin is a cyclic olefin component and is not particularly limited as long as it is a polyolefin resin containing a cyclic olefin component in the main chain. For example, an addition polymer of a cyclic olefin or a hydrogen additive thereof, an addition copolymer of a cyclic olefin and an α-olefin, or a hydrogen additive thereof may be mentioned.
此外,作為環狀烯烴樹脂係在前述之聚合物,還包含對於具有極性基之不飽和化合物來進行接枝及/或共聚合者。 Further, the cyclic olefin resin is a polymer comprising the above-mentioned polymer, and further includes grafting and/or copolymerization of an unsaturated compound having a polar group.
作為極性基係可以列舉例如羧基、酸酐基、環氧基、胺基、醯胺基、酯基、羥基、磺基、磷基、膦基等,作為具有極性基之不飽和化合物係可以列舉(甲基)丙烯酸、順丁烯二酸、順丁烯二酸酐、衣康酸酐、環氧丙基(甲基)丙烯酸酯、(甲基)丙烯酸烷基(碳數1~10)酯、順丁烯二酸烷基 (碳數1~10)酯、(甲基)丙烯醯胺、(甲基)丙烯酸-2-羥基乙基等,最好是列舉羧基、酸酐基、環氧基、胺基、醯胺基、酯基、羥基、磺基、磷基、膦基。 Examples of the polar group include a carboxyl group, an acid anhydride group, an epoxy group, an amine group, a decylamino group, an ester group, a hydroxyl group, a sulfo group, a phosphorus group, a phosphino group, and the like. Examples of the unsaturated compound having a polar group include ( Methyl)acrylic acid, maleic acid, maleic anhydride, itaconic anhydride, glycidyl (meth) acrylate, alkyl (meth) acrylate (carbon number 1 to 10), cis Alkylene dialkyl (Carbon number 1 to 10) ester, (meth) acrylamide, (meth) acrylate 2-hydroxyethyl, etc., preferably a carboxyl group, an acid anhydride group, an epoxy group, an amine group, a decylamino group, Ester group, hydroxyl group, sulfo group, phosphorus group, phosphino group.
作為環狀烯烴樹脂係最好是環狀烯烴和α-烯烴之加成共聚物或其氫添加物。 The cyclic olefin resin is preferably an addition copolymer of a cyclic olefin and an α-olefin or a hydrogen additive thereof.
此外,作為包含環狀烯烴成分來成為共聚合成分之環狀烯烴系樹脂係也可以使用市面販賣之樹脂。作為市面販賣之環狀烯烴系樹脂係可以列舉例如TOPAS(註冊商標)(Topas Advanced Polymers公司製)、apel(註冊商標)(三井化學公司製)、ZEONEX(註冊商標)(日本ZEON公司製)、ZEONOR(註冊商標)(日本ZEON公司製)、ARTON(註冊商標)(JSR公司製)等。 Further, as the cyclic olefin resin which is a copolymer component and which contains a cyclic olefin component, a commercially available resin can also be used. The cyclic olefin resin which is commercially available, for example, TOPAS (registered trademark) (manufactured by Topas Advanced Polymers Co., Ltd.), apel (registered trademark) (manufactured by Mitsui Chemicals, Inc.), ZEONEX (registered trademark) (manufactured by Japan ZEON Co., Ltd.), ZEONOR (registered trademark) (manufactured by Japan ZEON Co., Ltd.), ARTON (registered trademark) (manufactured by JSR Corporation), and the like.
作為環狀烯烴和α-烯烴之加成共聚物係可以列舉包含[1]碳數2~20之α-烯烴成分和[2]藉由下列之通式(I)而表示之環狀烯烴成分之共聚物,來成為特別理想之例子。 Examples of the addition copolymer of a cyclic olefin and an α-olefin include [1] an α-olefin component having 2 to 20 carbon atoms and [2] a cyclic olefin component represented by the following general formula (I). The copolymer is a particularly desirable example.
(在化學式中,R1~R12係可以分別是相同或不同,由氫原子、鹵素原子和烴基而組成之群組來選出,R9和R10、R11和R12係可以呈一體化地形成2價之烴基,R9或R10和R11或R12係可以相互地形成環。此外,n係表示0或正整數,在n為2以上之狀態下,R5~R8係可以在各個之重複單位中,分別是相同或不同。) (In the chemical formula, R 1 to R 12 may be the same or different, and are selected from the group consisting of a hydrogen atom, a halogen atom and a hydrocarbon group, and R 9 and R 10 , R 11 and R 12 may be integrated. A divalent hydrocarbon group is formed, and R 9 or R 10 and R 11 or R 12 may form a ring with each other. Further, n represents 0 or a positive integer, and in the state where n is 2 or more, R 5 to R 8 are It can be the same or different in each repeating unit.)
就[1]碳數2~20之α-烯烴成分而進行說明。碳數2~20之α-烯烴係並無特別限定。可以列舉例如相同於日本特開2007-302722號之同樣者。此外,這些α-烯烴成分係可以單獨1種,也可以同時使用2種以上。在這些當中,最佳理想是單獨地使用乙烯。 The [1] α-olefin component having 2 to 20 carbon atoms will be described. The α-olefin having 2 to 20 carbon atoms is not particularly limited. For example, the same as the same as Japanese Patent Laid-Open No. 2007-302722 can be cited. Further, these α-olefin components may be used alone or in combination of two or more. Among these, the best ideal is to use ethylene alone.
就[2]藉由通式(I)來表示之環狀烯烴成分而進行說明。通式(I)之R1~R12係可以分別是相同或不同,由氫原子、鹵素原子和烴基而組成之群組來選出。 The cyclic olefin component represented by the general formula (I) will be described in [2]. The R 1 to R 12 groups of the formula (I) may be the same or different and are selected from the group consisting of a hydrogen atom, a halogen atom and a hydrocarbon group.
作為R1~R8之具體例係可以列舉例如氫原子;氟、氯、溴等之鹵素原子;甲基、乙基、丙基、丁基等之低級烷基等,這些係可以分別不同,也可以呈部分地不同,並且,也可以全部相同。 Specific examples of R 1 to R 8 include a hydrogen atom; a halogen atom such as fluorine, chlorine or bromine; and a lower alkyl group such as a methyl group, an ethyl group, a propyl group or a butyl group; these may be different. They may also be partially different, or they may all be the same.
此外,作為R9~R12之具體例係可以列舉例如氫原子;氟、氯、溴等之鹵素原子;甲基、乙基、丙基、異丙基、丁基、異丁基、己基、硬脂醯基等之烷基;環己基等之環烷基;苯基、甲苯基、乙苯基、異丙基苯基、萘基、蒽基等之取代或無取代之芳香族烴基;苄基、苯乙基、在其他之烷基來取代芳基之芳烷基等,這些係可以分別不同,也可以呈部分地不同, 並且,也可以全部相同。 Further, specific examples of R 9 to R 12 include a hydrogen atom; a halogen atom such as fluorine, chlorine or bromine; methyl group, ethyl group, propyl group, isopropyl group, butyl group, isobutyl group, hexyl group, and the like. An alkyl group such as a stearyl group; a cycloalkyl group such as a cyclohexyl group; a substituted or unsubstituted aromatic hydrocarbon group such as a phenyl group, a tolyl group, an ethylphenyl group, an isopropylphenyl group, a naphthyl group or a fluorenyl group; The group, the phenethyl group, the aralkyl group which substitutes the aryl group in other alkyl groups, etc. may be different, may be partially different, or may be all the same.
作為R9和R10或R11和R12呈一體化地形成2價之烴基之狀態下之具體例係可以列舉例如乙叉基、丙叉基、異丙叉基等之烷叉基等。 Specific examples of the state in which R 9 and R 10 or R 11 and R 12 are integrally formed to form a divalent hydrocarbon group include an alkylidene group such as an ethylidene group, a propylidene group or an isopropylidene group.
在R9或R10和R11或R12呈相互地形成環之狀態下,形成之環係可以是單環,也可以是多環,也可以是具有交聯之多環,也可以是具有雙鍵之環,並且,也可以是由這些環之組合而組成之環。此外,這些環係可以具有甲基等之取代基。 In a state in which R 9 or R 10 and R 11 or R 12 form a ring with each other, the ring system formed may be a single ring, a polycyclic ring, or a polycyclic ring having cross-linking, or may have The ring of double bonds, and may also be a ring composed of a combination of these rings. Further, these ring systems may have a substituent such as a methyl group.
作為藉由通式(I)而表示之環狀烯烴成分之具體例係可以列舉相同於日本特開2007-302722號之同樣者。 Specific examples of the cyclic olefin component represented by the general formula (I) include the same ones as those disclosed in JP-A-2007-302722.
這些環狀烯烴成分係可以是單獨1種,並且,也可以組合2種以上而使用。在這些當中,最好是單獨地使用二環[2.2.1]七-2-烯烴(慣用名稱:原菠烷)。 These cyclic olefin components may be used alone or in combination of two or more. Among these, it is preferred to use a bicyclo[2.2.1]hepta-2-olefin (common name: raw spinane) alone.
[1]碳數2~20之α-烯烴成分和[2]藉由通式(I)而表示之環狀烯烴成分之聚合方法以及得到之聚合物之氫添加方法係並無特別限定,可以按照習知之方法而進行。可以是無規共聚合,也可以是嵌段共聚合,但是,最好是無規共聚合。 [1] The α-olefin component having 2 to 20 carbon atoms and [2] the polymerization method of the cyclic olefin component represented by the formula (I) and the hydrogen addition method of the obtained polymer are not particularly limited, and may be Follow the conventional method. It may be a random copolymerization or a block copolymerization, but it is preferably a random copolymerization.
此外,即使是就使用之聚合觸媒而言,也並無特別限定,可以使用齊格勒-納塔(Ziegler-Natta)系、復分解系、芳環烯金屬衍生物系觸媒等之向來習知之觸媒,藉由習知之方法而得到環狀烯烴系樹脂。 In addition, the polymerization catalyst to be used is not particularly limited, and it is possible to use a Ziegler-Natta system, a metathesis system, an aromatic cycloolefin metal derivative catalyst, and the like. A conventional olefin-based resin is obtained by a conventional method.
接著,就其他之共聚合成分而簡單地進行說明。環狀烯烴系樹脂(A)係除了前述之[1]碳數2~20之α-烯烴成分和[2]藉由通式(I)而表示之環狀烯烴成分以外,也可以 在不損害本發明目的之範圍,配合需要而含有其他之可共聚之不飽和單體成分。 Next, the other copolymerization components will be briefly described. The cyclic olefin-based resin (A) may be in addition to the above-mentioned [1] α-olefin component having 2 to 20 carbon atoms and [2] a cyclic olefin component represented by the general formula (I). Other copolymerizable unsaturated monomer components are contained as needed in the range which does not impair the object of the present invention.
作為可以任意地共聚之不飽和單體係並無特別限定,但是,可以列舉例如在1分子內包含2個以上之碳-碳雙鍵之烴系單體等。作為在1分子內包含2個以上之碳-碳雙鍵之烴系單體之具體例係可以列舉相同於日本特開2007-302722號之同樣者。 The unsaturated single system which can be arbitrarily copolymerized is not particularly limited, and examples thereof include a hydrocarbon-based monomer containing two or more carbon-carbon double bonds in one molecule. Specific examples of the hydrocarbon-based monomer containing two or more carbon-carbon double bonds in one molecule are the same as those in JP-A-2007-302722.
在使用前述之環狀烯烴樹脂之狀態下,預填注射器用外筒係變硬。因此,即使是在預填注射器用外筒之內壁面之離模斜率(圖1(b)中之θ)變小之狀態下,如果離模斜率呈實質地成為零的話,則也在使用時,成為在按壓柱塞而擠出預填注射器用外筒內之藥劑之際之阻礙。此外,前述內壁面之離模斜率為0度係表示構成射出成形用模具之芯部之離模斜率呈實質地成為0度。 In the state in which the above-mentioned cyclic olefin resin is used, the outer cylinder for prefilling the syringe is hardened. Therefore, even in the state where the mold release slope (the θ in Fig. 1(b)) becomes smaller in the inner wall surface of the outer cylinder for the prefilled syringe, if the mold release slope becomes substantially zero, it is also used. It is a hindrance when the plunger is pressed and the drug in the outer cylinder for the syringe is pre-filled. Further, the mold release slope of the inner wall surface is 0 degree, and the mold release slope of the core portion constituting the injection molding die is substantially 0 degree.
在使用樹脂而製造預填注射器用外筒之狀態下,為了容易由模具來取出在製造即刻後之預填注射器用外筒,因此,預填注射器用外筒之內壁面之離模斜率係最好是呈實質地不成為零。但是,如果是使用前述之模具的話,則即使是在前述之離模斜率呈實質地成為零之狀態下,也容易由模具來取出在製造即刻後之預填注射器用外筒。 In the state in which the outer cylinder for the prefilled syringe is manufactured by using the resin, in order to easily take out the outer cylinder for the prefilled syringe immediately after the manufacture, the mold release slope of the inner wall of the outer cylinder for prefilling the syringe is the most The good thing is that it does not become zero in substance. However, if the above-described mold is used, even in the state where the above-described mold release slope is substantially zero, it is easy to take out the outer cylinder for prefilled syringe immediately after the manufacture by the mold.
在此,所謂前述之離模斜率呈實質地成為零係指離模斜率成為0.5度以下之狀態。接著,在離模斜率成為0.5度以下之狀態下,發生前述之不容易取出之問題。 Here, the above-described mold release slope is substantially zero and the mold release slope is in a state of 0.5 degrees or less. Then, in a state where the mold release slope is 0.5 degrees or less, the above-described problem that it is not easy to take out occurs.
此外,可以在環狀烯烴樹脂組成物,以不損害本 發明效果之範圍,來包含環狀烯烴樹脂以外之成分。作為其他之成分係列舉例如其他之樹脂、無機填充劑、核劑、顏料、氧化防止劑、安定劑、可塑劑、滑劑、離模劑等。 In addition, the cyclic olefin resin composition can be used without damaging the present The range of the effects of the invention includes components other than the cyclic olefin resin. Examples of other components include other resins, inorganic fillers, nucleating agents, pigments, oxidation inhibitors, stabilizers, plasticizers, slip agents, release agents, and the like.
本發明之預填注射器用外筒係藉由射出成形法而進行製造。射出成形之製造條件係並無特別限定,配合使用之環狀烯烴樹脂組成物而適度地設定。 The outer cylinder for a prefilled syringe of the present invention is produced by an injection molding method. The production conditions for the injection molding are not particularly limited, and are appropriately set in accordance with the cyclic olefin resin composition to be used.
藉由本發明之製造方法而製造之預填注射器用外筒係具有高度之透明性。具體地說,對於預填注射器用外筒之側壁呈垂直地射入之波長450nm之光來透過前述側壁時之光線透過率係70%以上。 The outer cylinder for a prefilled syringe manufactured by the production method of the present invention has a high degree of transparency. Specifically, the light transmittance at the wavelength of 450 nm which is perpendicularly incident on the side wall of the outer cylinder for prefilled syringe is 70% or more.
此外,預填注射器用外筒之表面積越大而越加不容易由模具來取出在製造即刻後之預填注射器用外筒。預填注射器用外筒之長度L係通常為30mm以上、150mm以下,預填注射器用外筒之內徑R係通常為2mm以上、50mm以下。 Further, the larger the surface area of the outer cylinder for prefilling the syringe, the more difficult it is to take out the outer cylinder for the prefilled syringe immediately after manufacture by the mold. The length L of the outer cylinder for the prefilled syringe is usually 30 mm or more and 150 mm or less, and the inner diameter R of the outer cylinder for the prefilled syringe is usually 2 mm or more and 50 mm or less.
在以下,根據實施例而更加具體地說明本發明,但是,本發明係並非由於這些實施例而受到限定。 In the following, the present invention will be more specifically described based on the examples, but the present invention is not limited by these examples.
在本實施例,製造圖1所示之形狀之預填注射器用外筒。該預填注射器用外筒之尺寸係顯示於圖2(a)。此外,正如圖2(a)所示,在實施例來製造之預填注射器用外筒係內壁面之離模斜率為0度。 In the present embodiment, an outer cylinder for a prefilled syringe of the shape shown in Fig. 1 was produced. The size of the outer cylinder for the prefilled syringe is shown in Fig. 2(a). Further, as shown in Fig. 2(a), the mold release slope of the inner wall surface of the outer cylinder for the prefilled syringe manufactured in the example was 0 degree.
具有前述預填注射器用外筒之形狀之空腔之模具係包括圖2(b)所示之形狀之澆口、澆道和閘門。閘門之位置G係也顯示於圖2(a)。此外,正如圖2(b)所示,澆口之直徑、澆道之長度和閘門之直徑係分別為4.0mm、20mm、3.0mm。接著,正如圖2(b)所示,在澆口和澆道之連接點、以及澆道和閘門之連接點,設置3個之噴射渦輪(PIN1~3)。此外,在藉由PIN1而表示之噴射渦輪,連接用以測定離模抵抗之壓力感測器(「9223A」、日本Kistler公司製)。由該壓力感測器而得到之資料係使用工業用負載放大器(「5073A」、日本Kistler公司製)而進行變換,變換之資料係可以藉由DATAFLOW Light Ⅱ(日本Kistler公司製)而進行監視。 The mold having the cavity of the shape of the outer cylinder for prefilling the syringe described above includes a gate, a runner and a gate of the shape shown in Fig. 2(b). The position G of the gate is also shown in Figure 2(a). Further, as shown in Fig. 2(b), the diameter of the gate, the length of the runner, and the diameter of the gate are 4.0 mm, 20 mm, and 3.0 mm, respectively. Next, as shown in Fig. 2(b), three injection turbines (PINs 1 to 3) are provided at the connection point of the gate and the runner, and the connection point between the runner and the gate. Further, a pressure sensor ("9223A", manufactured by Kistler Co., Ltd., Japan) for measuring the mold release resistance is connected to the injection turbine indicated by PIN1. The data obtained by the pressure sensor was converted using an industrial load amplifier ("5073A", manufactured by Kistler, Japan), and the converted data can be monitored by DATAFLOW Light II (manufactured by Kistler Co., Ltd., Japan).
接著,準備藉由表1所示之條件而處理表面之模具。表1之「粒度之支數」係表示為了處理芯部之表面而使用之研磨材料之粒度支數。實施例1~3及比較例1~5係使用鑽石研磨粒而進行之空氣研磨處理,實施例4及比較例6~8係使用鑽石糊膏而藉由車床來進行之研磨處理。此外,表1之「塗佈」係表示形成於表面處理之芯部表面之潤滑性硬質皮膜之種類。在本實施例,在Ni之狀態下,藉由無電解電鍍法而形成潤滑性硬質皮膜,在CrN和TiN之狀態下,藉由PVD法而形成潤滑性硬質皮膜,在DLC之狀態下,藉由離子化蒸鍍法而形成潤滑性硬質皮膜。此外,在實施例1,藉由2000號之鑽石紙而研磨潤滑性硬質皮膜之表面,就實施例2和實施例4而言,藉由4000號之鑽石紙而研磨潤滑性硬質皮膜之表面,在實施例3,藉由8000號之鑽石紙而研磨潤滑性硬質皮膜之表 面。此外,使用於本實施例之芯部之鋼材係使用日立金屬股份有限公司製之HPM-38(淬火)。 Next, the mold of the surface was prepared by the conditions shown in Table 1. The "number of particles" in Table 1 indicates the particle size count of the abrasive material used to treat the surface of the core. Examples 1 to 3 and Comparative Examples 1 to 5 were air-polished by using diamond abrasive grains, and Example 4 and Comparative Examples 6 to 8 were polished by a lathe using a diamond paste. In addition, the "coating" of Table 1 shows the kind of the lubricious hard film formed in the surface of the surface-treated core part. In the present embodiment, a lubricative hard film is formed by electroless plating in the state of Ni, and a lubricative hard film is formed by the PVD method in the state of CrN and TiN, and in the state of DLC, A lubricative hard film is formed by ionization vapor deposition. Further, in Example 1, the surface of the lubricious hard film was polished by diamond paper No. 2000, and in the second and fourth embodiments, the surface of the lubricious hard film was ground by diamond paper of No. 4000. In Example 3, the surface of the lubricious hard film was ground by diamond paper of 8000 surface. Further, the steel material used in the core portion of the present embodiment was HPM-38 (quenched) manufactured by Hitachi Metals Co., Ltd.
使用KEYENCE股份有限公司製之「超深度彩色3D形狀測定顯微鏡VK-9500」,藉由按照JIS B 0601-1994之方法而測定芯部表面之表面粗糙度Rz、潤滑性硬質皮膜表面之表面粗糙度Rz以及研磨後之潤滑性硬質皮膜表面之表面粗糙度Rz。將測定之結果,顯示於表1。此外,表1中之單位係μm。 The surface roughness Rz of the surface of the core and the surface roughness of the surface of the lubricious hard film were measured by the method of JIS B 0601-1994 using the "Ultra Deep Color 3D Shape Measuring Microscope VK-9500" manufactured by KEYENCE Co., Ltd. Rz and the surface roughness Rz of the surface of the lubricious hard film after polishing. The results of the measurement are shown in Table 1. Further, the unit in Table 1 is μm.
作為環狀烯烴樹脂組成物係使用原菠烷和乙烯之共聚物(TOPAS 6013S-04、Topas Advanced Polymers公司製、玻璃轉移溫度138℃),製造實施例及比較例之預填注射器用外筒。此外,製造條件係模具溫度為105℃、圓筒溫度為280℃。 As a cyclic olefin resin composition, a copolymer of raw spinel and ethylene (TOPAS 6013S-04, manufactured by Topas Advanced Polymers Co., Ltd., glass transition temperature: 138 ° C) was used, and an outer cylinder for prefilled syringes of Examples and Comparative Examples was produced. Further, the production conditions were a mold temperature of 105 ° C and a cylinder temperature of 280 ° C.
在由模具來取出製造即刻後之預填注射器用外筒之際,藉由前述之壓力感測器而測定施加於PIN1之壓力。測定之結果(實施例1~4及比較例1~8之各測定之最大值)成為離模抵抗值而顯示於表1。此外,離模抵抗值未滿10.0MPa者係連續成形性成為「○」,10.0MPa以上者係連續成形性成為「×」。 The pressure applied to the PIN 1 was measured by the aforementioned pressure sensor while the outer cylinder for pre-filling the syringe immediately after the manufacture was taken out by the mold. The results of the measurement (the maximum values of the respective measurements of Examples 1 to 4 and Comparative Examples 1 to 8) were shown in Table 1 as the mold release resistance values. In addition, when the mold resistance value is less than 10.0 MPa, the continuous formability is "○", and the continuous formability of "10.0 MPa or more" is "X".
實施例1~4及比較例1~8之預填注射器用外筒之透明性係使用在日本分光股份有限公司製之「紫外線可見分光光度計、V-570」來安裝「積分球裝置、ISN-470型」之 裝置而進行測定。樣本係在預填注射器用外筒來延伸之方向,切段注射器而成為一半,由這裡而切出分割為2個之圓筒形狀之樣本(在此,由吸引部和預填注射器用外筒之連結位置開始切出17.5mm附近。),正如圖3所示,將切出之樣本,安裝於樣本固定座架,測定相對於450nm光之光線透過率。將測定之結果,顯示於表1。表1中之單位係%。 The transparency of the outer cylinder for the prefilled syringes of Examples 1 to 4 and Comparative Examples 1 to 8 was carried out by using an "ultraviolet-visible spectrophotometer, V-570" manufactured by JASCO Corporation. -470 type" The device was measured. The sample is in the direction in which the outer cylinder for prefilling the syringe is extended, and the syringe is cut into half, and a cylindrical sample divided into two is cut out therefrom (here, the suction tube and the outer cylinder for the prefilled syringe) The connection position was cut out in the vicinity of 17.5 mm.) As shown in Fig. 3, the cut sample was attached to the sample holder, and the light transmittance with respect to 450 nm light was measured. The results of the measurement are shown in Table 1. The unit in Table 1 is %.
藉由目視而確認實施例1~4及比較例1~8之預填注射器用外筒之表面傷痕。就有無傷痕而言,進行以下之二階段評價。將評價之結果,顯示於表1。 The surface flaws of the outer cylinders for the prefilled syringes of Examples 1 to 4 and Comparative Examples 1 to 8 were confirmed by visual observation. In the case of no scars, the following two stages of evaluation are performed. The results of the evaluation are shown in Table 1.
「○」:傷痕為3條以下之狀態 "○": The state of the scar is 3 or less
「×」:傷痕為4條以上之狀態 "X": The state of the scar is more than 4
由表1之結果而確認:可以藉由在製造對於環狀烯烴樹脂組成物來進行射出成形而組成之預填注射器用外筒 的方法,將在表面粗糙度Rz為50μm以下之芯部來形成包含由Ti、Cr、Zr、C、Al和Ni而選出之至少一種元素之潤滑性硬質皮膜且研磨該潤滑性硬質皮膜之表面的射出成形用模具予以使用,來作為射出成形用模具,而以高度之生產性,來製造無傷痕且透明性呈良好之預填注射器用外筒。 It is confirmed from the results of Table 1 that the outer cylinder for prefilled syringes can be formed by injection molding for the formation of a cyclic olefin resin composition. A method of forming a lubricative hard film containing at least one element selected from Ti, Cr, Zr, C, Al, and Ni and grinding the surface of the lubricious hard film in a core having a surface roughness Rz of 50 μm or less The injection molding die is used as an injection molding die, and a high-productivity is produced to produce a pre-filled syringe outer cylinder which is free from scratches and has good transparency.
1‧‧‧預填注射器 1‧‧‧Prefilled syringe
10‧‧‧預填注射器用外筒 10‧‧‧Prefilled syringe outer cylinder
20‧‧‧插管 20‧‧‧Intubation
30‧‧‧柱塞 30‧‧‧Plunger
101‧‧‧吸引部 101‧‧‧Attraction
102‧‧‧凸緣 102‧‧‧Flange
201‧‧‧擋塊 201‧‧ ‧block
Claims (4)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011284401A JP2013132394A (en) | 2011-12-26 | 2011-12-26 | Method for manufacturing outer cylinder for prefilled syringe, and method for manufacturing injection molding die |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201334824A true TW201334824A (en) | 2013-09-01 |
Family
ID=48696947
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW101144107A TW201334824A (en) | 2011-12-26 | 2012-11-26 | Production method for pre-filled syringe outer tube and production method for injection molding mold |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2013132394A (en) |
TW (1) | TW201334824A (en) |
WO (1) | WO2013099447A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7155003B2 (en) * | 2016-04-25 | 2022-10-18 | テルモ株式会社 | Syringe barrels and prefilled syringes |
WO2018063988A1 (en) * | 2016-09-27 | 2018-04-05 | Bayer Healthcare Llc | Rotary injection molding apparatus for producing plastic components such as syringes |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0884773A (en) * | 1994-09-14 | 1996-04-02 | Taisei Kako Kk | Syringe cylinder made of amorphous resin without draft angle and method for injection molding thereof |
JPH10264209A (en) * | 1997-03-24 | 1998-10-06 | Mazda Motor Corp | Mold structure, its production and use, and resin molded product |
JPH11277581A (en) * | 1998-03-30 | 1999-10-12 | Fuji Photo Optical Co Ltd | Method and mold for injection-molding synthetic resin member |
JP2002225088A (en) * | 2001-01-30 | 2002-08-14 | Polyplastics Co | Mirror surface finished mold to which surface treatment is applied and molding method |
JP2004136476A (en) * | 2002-10-16 | 2004-05-13 | Nippon Zeon Co Ltd | Molded product manufacturing method |
JP2005137771A (en) * | 2003-11-10 | 2005-06-02 | Daikyo Seiko Ltd | Medical treatment apparatus and method for producing it wherein fluorine-containing layer fixed on medical liquid contacting surface is formed |
JP4327051B2 (en) * | 2004-09-08 | 2009-09-09 | 山陽特殊製鋼株式会社 | Steel for plastic molds with excellent specularity |
JP5483384B2 (en) * | 2007-06-01 | 2014-05-07 | 国立大学法人豊橋技術科学大学 | DLC film and DLC coated mold |
JP5345826B2 (en) * | 2008-11-06 | 2013-11-20 | ポリプラスチックス株式会社 | Light guide plate |
-
2011
- 2011-12-26 JP JP2011284401A patent/JP2013132394A/en active Pending
-
2012
- 2012-11-07 WO PCT/JP2012/078885 patent/WO2013099447A1/en active Application Filing
- 2012-11-26 TW TW101144107A patent/TW201334824A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2013099447A1 (en) | 2013-07-04 |
JP2013132394A (en) | 2013-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2020201401B2 (en) | Three-position plungers, film coated plungers and related syringe assemblies | |
EP3055007B1 (en) | Convertible plungers, film coated plungers and related syringe assemblies | |
JP5717593B2 (en) | Mold for molding gasket for prefilled syringe | |
EP2593286B1 (en) | Injection molding process | |
KR910005704B1 (en) | Medical instrument and production thereof | |
JP2006519070A (en) | Piston assembly for syringe | |
EP2519291A1 (en) | Medical components having coated surfaces exhibiting low friction and/or low gas/liquid permeability | |
TW201334824A (en) | Production method for pre-filled syringe outer tube and production method for injection molding mold | |
CN109594042A (en) | Anti- adherency hard coat and preparation method thereof for injection mold | |
US20200164147A1 (en) | Syringe barrel and syringe | |
TW201334823A (en) | Production method for outer tube for pre-filled syringe | |
JP2009207619A (en) | Medical container | |
JP2008207219A (en) | Pressing die | |
JP2006288652A (en) | Cylinder of syringe, manufacturing method for it, manufacturing method of lubricating thin layer derived from fluorine resin | |
JP5463216B2 (en) | Chromium hard coating, mold having chromium hard coating formed on the surface, and method for producing chromium hard coating | |
CA2927340C (en) | Methods and apparatuses for injection molding walled structures | |
JP5345826B2 (en) | Light guide plate | |
JP2007276342A (en) | Gas-barrier resin molded article and its production method | |
CA3024396C (en) | Methods of improving adhesion of non-di-(2-ethylhexyl)phthalate polyvinyl chloride to an acrylic- or abs-based polymer | |
JP2019177497A (en) | Gas barrier molded body | |
JP2022019242A (en) | Urinary tract-indwelling catheter | |
NZ759333B2 (en) | Three-position plungers, film coated plungers and related syringe assemblies | |
JP2012000795A (en) | Resin coating molding and method of manufacturing the same |